Results indicated that both dPEDE-A@M32 and anti-PD-1 alone slowed tumor growth in mice; however, their combination exhibited a significantly greater inhibitory effect, leading to a marked reduction in tumor volume (Figure 7C-D). The gene discussed is PDCD1; the disease is neoplasm.